1st Quarter - Report

TIBER CREEK HEALTH STRATEGIES, INC. for NOVARTIS

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); H.R. 5547/S. 476 - Maintaining Investments in New Innovation Act (118th Congress).

LobbyistCovered position, as disclosed
JAMES BRYANT HALL —

Contacted: SENATE

Bills named: S. 476 (119th), H.R. 5547 (119th)

Health Issues HCR

Issues related to PBM reform.

LobbyistCovered position, as disclosed
JAMES BRYANT HALL —

Contacted: SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.